Circulars

Back to Circulars

30 April 2020

Safety Alerts for Pharmaceutical Products & Devices

Reference: CIR-2019-00000224

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

  • Medical device field safety action Alaris infusion Sets and Alaris 8100 Pump Module
  • Medical device field safety action Prismaflex sets family & MARS kits
  • Quarantine & Stop the importation of two lots of pharmaceutical product Dalacin C 75mg-5ml
  • Recall one lot of pharmaceutical product Methylene blue USP 10mg-ml injections
  • Recall one lot of pharmaceutical product Rumafen 50mg Tablet
  • Safety update of a pharmaceutical product Amiodarone Hydrochloride
  • Recall multiple lots of Homeopathic powder Weleda Baby Teething Powder 60g
  • Recall & Suspension of Registration of Pharmaceutical Product Pentasa sachet 1 gm

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Medical device field safety action Alaris infusion Sets and Alaris 8100 Pump Module.pdf:

View Document

Medical device field safety action Prismaflex sets family _ MARS kits.pdf:

View Document

Quarantine _ Stop the importation of two lots of pharmaceutical product Dalacin C 75mg-5ml.pdf:

View Document

Recall one lot of pharmaceutical product Methylene blue USP 10mg-ml injections.pdf:

View Document

Recall one lot of pharmaceutical product Rumafen 50mg Tablet.pdf:

View Document

Safety update of a pharmaceutical product Amiodarone Hydrochloride.pdf:

View Document

Recall multiple lots of Homeopathic powder Weleda Baby Teething Powder 60g.pdf:

View Document

Recall _ Suspension of Registration of Pharmaceutical Product Pentasa sachet 1 gm.pdf:

View Document

Close